Short Information | Inhibikase Therapeutics Inc. (NASDAQ:IKT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 415,393 |
Total Actual Volume | 1,299,651 |
Short Trends | |
---|---|
Cover Days | 14 |
Short Days | 1 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 20,770 |
Average Short Percentage | 27.93% |
Is there a IKT Short Squeeze or Breakout about to happen?
See the IKT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-09-2024 | $1.39 | $1.36 | $1.39 | $1.35 | 34,662 | 7,597 | 21.92% |
05-08-2024 | $1.31 | $1.4 | $1.55 | $1.31 | 34,551 | 2,259 | 6.54% |
05-07-2024 | $1.29 | $1.26 | $1.3 | $1.2 | 30,515 | 7,834 | 25.67% |
05-06-2024 | $1.4 | $1.29 | $1.45 | $1.29 | 71,291 | 15,056 | 21.12% |
05-03-2024 | $1.38 | $1.39 | $1.51 | $1.3304 | 46,966 | 5,233 | 11.14% |
05-02-2024 | $1.39 | $1.34 | $1.4 | $1.29 | 69,386 | 28,821 | 41.54% |
05-01-2024 | $1.43 | $1.35 | $1.45 | $1.35 | 94,289 | 32,428 | 34.39% |
04-30-2024 | $1.54 | $1.47 | $1.595 | $1.43 | 57,434 | 15,659 | 27.26% |
04-29-2024 | $1.65 | $1.59 | $1.78 | $1.59 | 40,442 | 9,999 | 24.72% |
04-26-2024 | $1.67 | $1.71 | $1.82 | $1.67 | 98,983 | 52,833 | 53.38% |
04-25-2024 | $1.82 | $1.9 | $1.9 | $1.7119 | 21,668 | 9,558 | 44.11% |
04-24-2024 | $1.63 | $1.87 | $1.87 | $1.5432 | 62,107 | 23,374 | 37.64% |
04-23-2024 | $1.44 | $1.58 | $1.61 | $1.42 | 78,470 | 34,463 | 43.92% |
04-22-2024 | $1.96 | $1.37 | $1.96 | $1.29 | 369,205 | 126,411 | 34.24% |
04-19-2024 | $2.12 | $2.04 | $2.13 | $2.02 | 52,727 | 16,661 | 31.6% |
04-18-2024 | $2.102 | $2.1 | $2.15 | $2.0435 | 27,638 | 2,633 | 9.53% |
04-17-2024 | $2.2 | $2.13 | $2.2 | $2.11 | 37,008 | 7,633 | 20.63% |
04-16-2024 | $2.298 | $2.126 | $2.3 | $2.126 | 13,062 | 2,474 | 18.94% |
04-15-2024 | $2.19 | $2.195 | $2.25 | $2.1448 | 27,860 | 10,498 | 37.68% |
04-12-2024 | $2.18 | $2.19 | $2.23 | $2.15 | 31,387 | 3,969 | 12.65% |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or ...
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist a...
A look at the top 10 most actives in the United States AGBA Group Holding Limited (AGBA) rose 100.0% to $2.5 on volume of 201,539,290 shares PROSHARES TRUST (SQQQ) fell 2.9% to $12.47 on volume of 154,254,858 shares Tesla Inc. (TSLA) fell 3.4% to $142.05 on volume of 106,267,579 shares ...